Literature DB >> 25179158

Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma.

Guillaume Velut1, Florence Mary1, Philippe Wind2, Thomas Aparicio3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25179158     DOI: 10.1016/j.dld.2014.08.036

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  6 in total

1.  Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.

Authors:  Xiang-Yu Zeng; Yu-Ping Yin; Hua Xiao; Peng Zhang; Jun He; Wei-Zhen Liu; Jin-Bo Gao; Xiao-Ming Shuai; Guo-Bin Wang; Xiu-Li Wu; Kai-Xiong Tao
Journal:  Curr Med Sci       Date:  2018-12-07

Review 2.  Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge.

Authors:  Jon Arne Søreide; Ole Jacob Greve; Einar Gudlaugsson; Svein Størset
Journal:  Scand J Gastroenterol       Date:  2016-01-05       Impact factor: 2.423

3.  The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.

Authors:  Kai Zhou; Anqiang Wang; Sheng Ao; Jiahui Chen; Ke Ji; Qifei He; Xin Ji; Xiaojiang Wu; Ji Zhang; Zhongwu Li; Zhaode Bu; Jiafu Ji
Journal:  BMC Cancer       Date:  2020-07-17       Impact factor: 4.430

Review 4.  Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.

Authors:  Jietao Lin; Yang Cao; Ling Yu; Lizhu Lin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

Review 5.  Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuwen Zhou; Yuqing Wang; Jiaming Yuan; Xuelei Ma
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

6.  Computed Tomography Features and Clinical Prognostic Characteristics of Hepatoid Adenocarcinoma of the Stomach.

Authors:  Wen-Peng Huang; Li-Ming Li; Jing Li; Jun-Hui Yuan; Ping Hou; Chen-Chen Liu; Yi-Hui Ma; Xiao-Nan Liu; Yi-Jing Han; Pan Liang; Jian-Bo Gao
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.